An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial) - Wang, Huai-Yu; Gong, Sha; Li, Guo-Hui; Yao, Ya-Zhou; Zheng, Yin-Suo; Lu, Xiao-Hong; Wei, Su-Hua; Qin, Wei-Wei; Liu, Hai-Bo; Wang, Meng-Chang; Xi, Jie-Ying; Chen, Li-Mei; et al. (Blood cancer journal (New York), 2022)
Keywords: 692/308/2779/777; 692/699/67/1990/283/1897; Arsenic; Arsenic Trioxide - therapeutic use; Arsenicals - therapeutic use; Biomedical and Life Sciences; Biomedicine; Cancer Research; Chemotherapy; Hematology; Humans; Leukemia; Leukemia, Promyelocytic, Acute - drug therapy; Oncology; Oxides - therapeutic use; Treatment Outcome; Tretinoin - therapeutic use